Study S001689

GLP-1 Agonists as Neoadjuvant Therapy for Surgical Treatment of Type 2 Diabetes: A Randomized Controlled Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT04624672
Acronym: NOVO-GLP1
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: SINGLE
Status: TERMINATED
Enrollment: 3
Start: 2021-08-25
Primary completion: 2022-07-18
Lead sponsor: Geisinger Clinic
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG:Semaglutide (1 Mg Dose); DRUG:Placebo
Results posted: TRUE
Individual participant data sharing: NO
Secondary identifiers: OTHER:U1111-1242-4068

Registered primary outcomes

RATE OF PARTIAL REMISSION OF DIABETES [11 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.